CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 535 enrolled
Drug / intervention
Experimental: Pharmacist-Bidirectional Texting Group +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03986931
NCT03986931N/ACompleted

A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting

Linnea Polgreen·interventional·Posted Jun 14, 2019·Updated Jan 22, 2025

In Brief

A clinical study evaluating Experimental: Pharmacist-Bidirectional Texting Group and Active Comparator: Control Group for Hypertension. Completed, enrolled 535 participants across 1 site.

Detailed Summary

Bidirectional texting is an effective way to collect home blood pressure (BP) measurements from subjects, but collecting BP measurements and sending them to physicians does not necessarily lead to decreased BP. Pharmacist interventions have been successful in decreasing subject BP. However, pharmacists are expensive, and in successful interventions, spent a substantial amount of time collecting home BP measurements. In this study, a proven pharmacist intervention will be added to a bidirectional texting program to determine if a combined pharmacist-bidirectional texting intervention is successful at decreasing subject BP and increasing subject BP treatment intensification in a cost-effective manner. This study will be a cluster-randomized, controlled trial of a new intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 14, 2019
Enrollment StartFeb 25, 2020
Primary CompletionJun 22, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 7.0 years ago

Interventions

Experimental: Pharmacist-Bidirectional Texting Groupother

The goal of this intervention is to determine if bidirectional texting and pharmacist monitoring will improve blood pressure control.

Active Comparator: Control Groupother

This group will receive bidirectional texting, but no pharmacist monitoring.